Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient.
作者信息
Rizzo Alberto, Foschi Antonella, Bracchitta Fiorenza, Faggion Ivano, Salari Federica, Borgonovo Fabio, Fusetti Chiara, Mileto Davide, Rizzardini Giuliano, Lombardi Alessandra, Gismondo Maria R, Micheli Valeria
机构信息
Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco - L. Sacco Hospital, Milan, Italy.
Department of Infectious Diseases, ASST Fatebenefratelli Sacco - L. Sacco Hospital, Milan, Italy.
出版信息
J Med Virol. 2023 Jan;95(1):e28381. doi: 10.1002/jmv.28381.
Abstract
摘要
相似文献
1
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient.
J Med Virol. 2023 Jan;95(1):e28381. doi: 10.1002/jmv.28381.
2
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era.
New Microbiol. 2022 Dec;45(4):355-357. Epub 2022 May 23.
3
Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing.
Clin Transl Med. 2023 Nov;13(11):e1462. doi: 10.1002/ctm2.1462.
4
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
Int J Infect Dis. 2022 Sep;122:444-448. doi: 10.1016/j.ijid.2022.06.023. Epub 2022 Jun 18.
5
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
Int J Infect Dis. 2021 Mar;104:379-381. doi: 10.1016/j.ijid.2020.12.050. Epub 2020 Dec 21.
6
Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.
Microbiol Spectr. 2022 Jun 29;10(3):e0079122. doi: 10.1128/spectrum.00791-22. Epub 2022 May 11.
7
Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.
J Med Virol. 2022 Mar;94(3):1241-1245. doi: 10.1002/jmv.27445. Epub 2021 Nov 13.
8
SARS-CoV-2 Reinfection in a Liver Transplant Recipient.
Ann Intern Med. 2021 Aug;174(8):1178-1180. doi: 10.7326/L21-0108. Epub 2021 Apr 20.
9
A Short Series of Case Reports of COVID-19 in Immunocompromised Patients.
Viruses. 2022 Apr 29;14(5):934. doi: 10.3390/v14050934.
10
COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.
Int J Infect Dis. 2022 Jan;114:178-182. doi: 10.1016/j.ijid.2021.10.045. Epub 2021 Oct 29.
引用本文的文献
1
Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient.
Viruses. 2025 Jan 23;17(2):147. doi: 10.3390/v17020147.
本文引用的文献
1
Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment.
Viruses. 2022 Aug 11;14(8):1757. doi: 10.3390/v14081757.
2
Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: Prospective cohort study and validation cohort.
J Med Virol. 2022 Nov;94(11):5260-5270. doi: 10.1002/jmv.27989. Epub 2022 Aug 9.
3
Virologic and Immunologic Characterization of Coronavirus Disease 2019 Recrudescence After Nirmatrelvir/Ritonavir Treatment.
Clin Infect Dis. 2023 Feb 8;76(3):e530-e532. doi: 10.1093/cid/ciac496.
4
Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases.
Front Immunol. 2022 Apr 14;13:860891. doi: 10.3389/fimmu.2022.860891. eCollection 2022.
5
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies.
EBioMedicine. 2022 Apr;78:103944. doi: 10.1016/j.ebiom.2022.103944.
6
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.
Nature. 2022 Apr;604(7906):553-556. doi: 10.1038/s41586-022-04594-4. Epub 2022 Mar 3.
7
Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection.
Emerg Microbes Infect. 2022 Dec;11(1):786-789. doi: 10.1080/22221751.2022.2045877.
8
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus.
Wellcome Open Res. 2020 Oct 12;5:181. doi: 10.12688/wellcomeopenres.16002.2. eCollection 2020.
9
A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge?
Int J Infect Dis. 2021 Mar;104:631-633. doi: 10.1016/j.ijid.2020.11.161. Epub 2020 Nov 20.
Zotero 插件